48 Pageviews Read Stories
Causes: Brain Disorders Research, Health, Mental Health, Mental Health Disorders, Mental Health Treatment, Neurology & Neuroscience Research
Mission: Cohen veterans bioscience is a national, nonpartisan 501(c)3 research organization dedicated to fast-tracking the development of diagnostic tests and personalized therapeutics for the millions of veterans and civilians who suffer the devastating effects of trauma-related and other brain disorders.
Programs: Post traumatic stress disorder ("ptsd") & traumatic brain injury ("tbi"):in july 2015, the cvb program was founded to establish a national research roadmap for ptsd, tbi and related conditions (e. G. Suicidality). Program activities focus on the discovery of biomarkers and biological pathways that are translationally relevant for the development of diagnostics and therapeutic targets for drug and other medical interventions and the creation of research tools (e. G. Animal models, data standards, computational models, reference databases, etc. ) that will accelerate/foster these discoveries. (continued sch o)cvb has established both intramural (research conducted by or including, cvb staff or contractors) and extramural research programs (research conducted via grants or in collaboration with external academic, industry, foundation and government partners).
cohen veterans bioscience co-leads a national veteran care summit focused on advancements in bioscience, clinical treatment, and precision medicine, and highlighted opportunities for advancing the ptsd and tbi research roadmap through public-private partnerships. World-renowned brain health experts share the state-of-the-art in biomarkers, diagnostics, translational models, genetics, biosensors and mobile health for ptsd and tbi. Top-level clinicians shared expertise and best practices around caring for veterans and military families. This event is attended by veterans advocacy, government, academic and industry thought leaders in clinical delivery, policy making, and scientific discovery.
the orion bionetworks flagship program successfully piloted the establishment of an ms bionetwork comprised of academic (neuroscience institute of the brigham and women's hospital), advocacy (accelerated cure project for ms), computational (gns healthcare, metacell, thomson reuters), informatics (converge by deloitte, rancho biosciences, exaptive), and online patient community partners (patientslikeme [plm]). De-identified hippa-compliant data from three databases werecurated and loaded into a cloud-based data knowledge management system called transmart. The integrated repository includes 9,000 subjects with ms and related conditions. The alliance developed a roadmap for joint execution with specific scientific aims. To date, the alliance has generated three models based on the data repository using differentalgorithmic approaches: phenotypic prognostic model and two molecular prognostic models.